A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery
Clinical trial NCT02691026 · TERMINATED
Trial details
- NCT number
- NCT02691026
- Sponsor
- Oslo University Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2020-12-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.